Skip to main content
. 2020 Feb 6;39(4):e30–e36. doi: 10.1097/INF.0000000000002580

FIGURE 1.

FIGURE 1.

Vaccine efficacy against symptomatic VCD due to any of the 4 serotypes by study phase and dengue serostatus at baseline in Colombia. Serostatus determined by PRNT (measured or imputed) at Month 0. n and N are average numbers from 10 iterations of multiple imputations. Study group classified as randomized (Subjects classified according to the injection assigned at randomization). N indicates total number of subjects selected in sub-cohort; n, number of subjects fulfilling the item listed; N/A, not available.